Skip to main content

Diabetes Mellitus: Pharmacotherapy- SGLT, Centrally Acting Dopamine Agonists & Bile Acid Sequestrants!

 PHARMACOTHERAPY:

Medications classifications include:

  1.  Sulfonyl Urea's
  2. Nonsylfonylurea Secretagogues (a-Glinides)
  3. Biguanides
  4. Thiazolidinediones
  5. a-Glucosidase Inhibitors
  6. Dipeptidyl Peptidase-4 Inhibitors (Gliptins)
  7. Sodium-glucose co-transporter (SGLT) Inhibitors 
  8. Central-Acting Dopamine Agonists
  9. Bile Acid Sequestrants
  10. Insulin therapy

7.SODIUM-GLUCOSE CO-TRANPORTER (SGLT-2) INHIBITORS

The drugs approved include Canagliflozin, Dapagliflozin, Empagliflozin.

Mechanism of Action:

  • Glucose is freely filtered buy the kidney glomeruli and is reabsorbed in the proximal convoluted tubules by the action of sodium glucose co-transporters (SGLT). SGLT accounts for 90% of the glucose reabsorption and its inhibition causes glycosuria in people with diabetes, lowering plasma glucose levels.

Dose:

Canagliflozin: 100 & 300mg- 100mg daily if usual dose. 300mg daily can be used if eGFR resulting in lowering HDL. 

Dapagliflozin: 3 & 10mg- 10 mg daily. 3mg daily in hepatic failure.

Empagliflozin: 10 & 25mg- 10mg daily. 25 mg daily can be used if necessary.


8.CENTRAL ACTING DOPAMINE AGONISTS

  • A quick release formulation of a central acting dopamine agonist Bromocriptine was approved by the FDA in May 2009 for the treatment of T2DM.

Mechanism of Action:

  • The exact mechanism of action of how bromocriptine regulates glycemic control is unknown, however, data indicates that bromocriptine administered in the morning improves insulin sensitivity and this is a likely result of its effect on dopamine oscillations.

Clinical use:

  • A modest A1c reduction of 0.1%-0.4% is expected from this drug.

Adverse Effects:

  • Rhinitis
  • Dizziness
  • Asthenia
  • Headache
  • Sinusitis
  • Constipation
  • Nausea

Dose:

  • When used to treat patients with T2DM, bromocriptine should be taken 2hr after waking up in the morning with food. 
  • The initial dose is 0.8mg, titrated up weekly until a maximum dosage of 4.8mg/day is achieved.

Contraindication:

  • It is contraindicated in patients with migraine and in women who are nursing.


9.BILE ACID SEQUESTRANTS

  • Colesevelam is the only bile acid sequestrant currently approved as the adjunctive therapy to improve glycemic control in conjunction with diet, exercise and insulin or oral agents for the treatment of T2 DM.

Mechanism of action:

It acts on the intestinal lumen to bind bile acid but whether this is the drugs only action that results in plasma glucose lowering or if a secondary systemic effect to bile acid binding is unknown.

Clinical use:

  • An A1c reduction of approximately 0.4% can be expected when added to metformin, sulfonylurea or insulin. 
  • FPG is reduced about 5-10mg/dL.
  • LDL cholesterol is reduced 12-16%

Dose:

  •   Dosing for T2DM is 6*625mg tablets daily which may be split into 3 tablets twice daily.

Adverse Effects:

  • Constipation
  • Dyspepsia
  • Drug-drug interactions with Levothyroxine, Glyburide, Oral contraceptives, Phenytoin, Warfarin, Digoxin
  • Malabsorption of fat-soluble vitamins A, D, E and K 

Labels:

Comments

Post a Comment

Popular posts from this blog

Drug-Induced Ototoxicity!

 DRUG-INDUCED OTOTOXICITY What is drug Induced Ototoxicity? Drug-Induced ototoxicity can affect hearing (auditory or cochlear function0, balance (vestibular function) depending on the drug. Drugs of almost every class have been reported to produce tinnitus (sounds in ear), as have placebos. The following agents are associated with measurable changes in hearing or vestibular defect when administered systemically. 1. AMINOGLYCOSIDES: Aminoglycosides antibiotics can cause cochlear or vestibular toxicities. Cochlear toxicity: occurs as progressive hear loss, starting with highest tones and advancing to lower tones. Thus, considerable damage can occur before the patient recognizes it. S ymptoms of Vestibular damage : include;  Dizziness Vertigo Ataxia Both forms of ototoxicity are bilateral and potentially reversible, but permanent damage is common and can progress even after discontinuation of aminoglycosides. Clinically detectable ototoxicity in as many as 5% patients. Most amin...
Post a Comment
Read more

Medical Emergency- Cardiac Arrest and Basic Life Support (BLS)!

  MEDICAL EMERGENCY- CARDIAC ARREST AND BASIC LIFE SUPPORT Definition: " Cardiac Arrest is a medical emergency requiring a systematic approach". Early recognition must be followed by prompt, effective application of Basic Life Support (BLS) techniques to sustain the patient until Advanced Life Support (ALS) capabilities are available. Management: The management of Cardiac Arrest is a 4-step approach: Recognition and Assessment BLS Advanced Cardiovascular Life Support (ACLS) Post-resuscitation Care 1. RECOGNITION AND ASSESMENT Verify that the respiration and circulation have ceased: Loss of consciousness Loss of functional ventilation (respiratory arrest or inadequate respiratory effort) Loss of functional perfusion (No pulse). 2. BASIC LIFE SUUPORT (BLS) The goal in cardiac arrest is the restoration of spontaneous circulation (ROSC). The first step towards achieving this ROSC goal is prompt initiation of BLS, where the goal is to rapidly and effectively perfuse the tissues wi...
Post a Comment
Read more

Diabetes Mellitus: Non-Pharmacological Therapy--MNT!

 NON PHARMACOLOGICAL THERAPY  MNT Glycemic Index Dietary supplements Weight measurements Physical Activity Psychological assessment Immunizations 1. MEDICAL NUTRITION THERAPY (MNT)  " Medical Nutrition Therapy (MNT) is a term used by the ADA to describe the optimal condition of caloric intake with other aspects of diabetes therapy (Insulin, Exercise, Weight loss)". The ADA has issued recommendations for three types of MNT: Primary prevention measures of MNT are directed at preventing or delaying the onset of type 2 Diabetes in high-risk individuals (obese or with pre-diabetes) by promoting weight reduction. Secondary prevention measures of MNT are directed at preventing or delaying-related complications in diabetic individuals by improving glycemic control. Tertiary prevention measures of MNT are directed at managing diabetes-related complications (cardiovascular disease, neuropathy) in diabetic individuals. Despite the popular notion, there is not any " Diabetic diet...
Post a Comment
Read more